Dave Damrau
Vice President of Global Clinical Operations for the Americas at Johnson & Johnson Innovative Medicine; previously Executive Director of Clinical Trial Management at Mural Oncology.
1
APPEARANCES
1
PODCASTS
Aug 28, 2026
Amy KramerGUEST
With eSource, we're seeing data accurately exchanged at 99.9%, which significantly reduces queries and improves confidence in the data.
Dave DamrauGUEST
And those metrics are impressive, Amy, but this is not just an operational inconvenience.
Dave DamrauGUEST
It's actually an opportunity for improvement to how we support our site partners in the way that our studies are being executed.
Dave DamrauGUEST
It has real implications for study quality, speed, the sustainability of our workforce, and really the overall research experience.
Dave DamrauGUEST
And at J&J, we really see a clear need to help advance models that are more sustainable for sites, but also more scalable for the industry holistically.
Dave DamrauGUEST
And EHR to Sponsor reflects that commitment to solving meaningful problems in ways that can improve research at scale.